Recombinant DNA Advisory Committee - 06/1-2/92 
Becky Lawson, OD 
Koichi Miyamura, NHLBI 
Richard Morgan, NHLBI 
Edward Oldfield, NINDS 
Joyce O'Shaughnessy, NCI 
Jack Ragheb, NHLBI 
Zvi Ram, NINDS 
Nava Sarver, NIAID 
Debra Wilson, OD 
Others: 
Paul Aebersold, Food and Drug Administration 
Jack Barber, Viagene 
James Barrett, Genetic Therapy, Inc. 
Malcolm Brenner, St. Jude Childrens Hospital 
Daniel Butler, Methodist Medical Center 
Tom Carlstrom, Iowa Methodist Health System 
C. Budd Colby, Colby Biomedical Consultants 
Wanda DeVlaminck, Somatix Therapy 
Dorothy Eberlin, NOVA Research 
Paul Evangelista, NOVA Research 
Carol Ezzell, Science News 
Wayne Ferman, St. Jude Childrens Hospital 
Jeffrey Fox, ASM News and Biotechnology 
Bernd Gansbacher, Memorial Sloan Kettering Cancer Center 
Nick Greiner, NHK, Japanese Public Television 
Russell Herndon, Genzyme Corporation 
John Jaugstetter, Genentech, Inc. 
Andy Kimbrell, Foundation on Economic Trends 
Rebecca Kolberg, United Press International 
Pat Kvochak, Office of the General Counsel, HHS 
Ron Leidelmeyer, NHK, Japanese Public Television 
Katherine Matthews, Foundation on Economic Trends 
Gerard McGarrity, Genetic Therapy, Inc. 
Ian McNiece, Amgen 
Keith McRoberts, Iowa Methodist Health System 
Jessica Meyerson, The Blue Sheet 
Robert Moen, Genetic Therapy, Inc. 
Donald Moorman, Iowa Methodist Health System 
Lisa Morris, Genetic Therapy, Inc. 
John Parker, The Blue Sheet 
[670] 
Recombinant DNA Research, Volume 15 
